Table 2
Open in new tab

Daily glucocorticoid and mineralocorticoid doses for age and sex groups and subgroups. Glucocorticoid doses are expressed as hydrocortisone-equivalent mg/m2/day and mineralocorticoid doses as fludrocortisone µg/m2/day and µg/day. The subgroup comparison was conducted for the relative doses for both GC and fludrocortisone. Daily doses are expressed as mean ± s.d. (n = number of participants included in the analysis).

GroupnDaily doseSubgroup comparison
Males vs females8–12 vs12–18 years8–12 vs12–18 years
MalesFemales
HC-equivalent (mg/m2/day)0.5440.0070.3730.008
 All10113.6 ± 3.6
 Males4713.8 ± 2.9
 Females5413.3 ± 4.2
 Age, years
  8–12 years4812.5 ± 3.0
  12–18 years5314.5 ±3.9
Fludrocortisone0.2310.1880.0630.808
 All82
  µg/m2/day105.6 ± 49.3
  µg/day154.3 ± 70.1
 Males40
  µg/m2/day115.1 ± 54.8
  µg/day169.8 ± 70.7
 Females42
  µg/m2/day96.5 ± 42.1
  µg/day139.6 ± 67.0
 Age, years
  8–12 years39
   µg/m2/day114.0 ± 52.9
   µg/day145.9 ± 64.1
  12–18 years43
   µg/m2/day98.3 ± 45.3
   µg/day161.6 ± 74.8
GroupnDaily doseSubgroup comparison
Males vs females8–12 vs12–18 years8–12 vs12–18 years
MalesFemales
HC-equivalent (mg/m2/day)0.5440.0070.3730.008
 All10113.6 ± 3.6
 Males4713.8 ± 2.9
 Females5413.3 ± 4.2
 Age, years
  8–12 years4812.5 ± 3.0
  12–18 years5314.5 ±3.9
Fludrocortisone0.2310.1880.0630.808
 All82
  µg/m2/day105.6 ± 49.3
  µg/day154.3 ± 70.1
 Males40
  µg/m2/day115.1 ± 54.8
  µg/day169.8 ± 70.7
 Females42
  µg/m2/day96.5 ± 42.1
  µg/day139.6 ± 67.0
 Age, years
  8–12 years39
   µg/m2/day114.0 ± 52.9
   µg/day145.9 ± 64.1
  12–18 years43
   µg/m2/day98.3 ± 45.3
   µg/day161.6 ± 74.8
Table 2
Open in new tab

Daily glucocorticoid and mineralocorticoid doses for age and sex groups and subgroups. Glucocorticoid doses are expressed as hydrocortisone-equivalent mg/m2/day and mineralocorticoid doses as fludrocortisone µg/m2/day and µg/day. The subgroup comparison was conducted for the relative doses for both GC and fludrocortisone. Daily doses are expressed as mean ± s.d. (n = number of participants included in the analysis).

GroupnDaily doseSubgroup comparison
Males vs females8–12 vs12–18 years8–12 vs12–18 years
MalesFemales
HC-equivalent (mg/m2/day)0.5440.0070.3730.008
 All10113.6 ± 3.6
 Males4713.8 ± 2.9
 Females5413.3 ± 4.2
 Age, years
  8–12 years4812.5 ± 3.0
  12–18 years5314.5 ±3.9
Fludrocortisone0.2310.1880.0630.808
 All82
  µg/m2/day105.6 ± 49.3
  µg/day154.3 ± 70.1
 Males40
  µg/m2/day115.1 ± 54.8
  µg/day169.8 ± 70.7
 Females42
  µg/m2/day96.5 ± 42.1
  µg/day139.6 ± 67.0
 Age, years
  8–12 years39
   µg/m2/day114.0 ± 52.9
   µg/day145.9 ± 64.1
  12–18 years43
   µg/m2/day98.3 ± 45.3
   µg/day161.6 ± 74.8
GroupnDaily doseSubgroup comparison
Males vs females8–12 vs12–18 years8–12 vs12–18 years
MalesFemales
HC-equivalent (mg/m2/day)0.5440.0070.3730.008
 All10113.6 ± 3.6
 Males4713.8 ± 2.9
 Females5413.3 ± 4.2
 Age, years
  8–12 years4812.5 ± 3.0
  12–18 years5314.5 ±3.9
Fludrocortisone0.2310.1880.0630.808
 All82
  µg/m2/day105.6 ± 49.3
  µg/day154.3 ± 70.1
 Males40
  µg/m2/day115.1 ± 54.8
  µg/day169.8 ± 70.7
 Females42
  µg/m2/day96.5 ± 42.1
  µg/day139.6 ± 67.0
 Age, years
  8–12 years39
   µg/m2/day114.0 ± 52.9
   µg/day145.9 ± 64.1
  12–18 years43
   µg/m2/day98.3 ± 45.3
   µg/day161.6 ± 74.8
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close